Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for Abivax (ABVX) over the last 4 years, with Q3 2025 value amounting to $10.7 million.

  • Abivax's Other Non-Current Assets changed N/A to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year change of. This contributed to the annual value of $8.1 million for FY2024, which is 4201.74% down from last year.
  • Latest data reveals that Abivax reported Other Non-Current Assets of $10.7 million as of Q3 2025.
  • In the past 5 years, Abivax's Other Non-Current Assets ranged from a high of $13.8 million in Q4 2023 and a low of $7.9 million during Q1 2025
  • Over the past 4 years, Abivax's median Other Non-Current Assets value was $10.7 million (recorded in 2025), while the average stood at $10.8 million.
  • As far as peak fluctuations go, Abivax's Other Non-Current Assets surged by 1592.53% in 2023, and later plummeted by 4170.6% in 2024.
  • Quarter analysis of 4 years shows Abivax's Other Non-Current Assets stood at $11.9 million in 2022, then grew by 15.93% to $13.8 million in 2023, then crashed by 41.71% to $8.1 million in 2024, then skyrocketed by 32.82% to $10.7 million in 2025.
  • Its Other Non-Current Assets stands at $10.7 million for Q3 2025, versus $9.1 million for Q2 2025 and $7.9 million for Q1 2025.